Agitation
89
9
10
51
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
18 trials with published results (20%)
Research Maturity
51 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
6 terminated out of 89 trials
89.5%
+3.0% vs benchmark
39%
35 trials in Phase 3/4
35%
18 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (89)
PARO-agitation-study
Neurosteer Bedside Monitoring System
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyperactive Delirium: Protocol of a Randomized Controlled Trial
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Nabilone for Agitation Blinded Intervention Trial
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Doll Therapy for Agitated Elderly Dementia People
Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery
Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury
Acute Agitation in Emergency Psychiatry
Treatment of Psychosis and Agitation in Alzheimer's Disease
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)